Adrenomed closes € 24 M financing led by Wellington and HBM
- The financing round was led by top-tier life science venture capitalists Wellington Partners and HBM Healthcare Investments, joined by existing shareholders
- The new funds will be used to execute a proof-of-concept clinical program of lead product…